These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20174617)

  • 21. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.
    D'Alise AM; Auyeung V; Feuerer M; Nishio J; Fontenot J; Benoist C; Mathis D
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19857-62. PubMed ID: 19073938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the aryl hydrocarbon receptor by TCDD inhibits mammary tumor metastasis in a syngeneic mouse model of breast cancer.
    Wang T; Wyrick KL; Meadows GG; Wills TB; Vorderstrasse BA
    Toxicol Sci; 2011 Dec; 124(2):291-8. PubMed ID: 21948867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AhR activation increases IL-2 production by alloreactive CD4
    Ehrlich AK; Pennington JM; Tilton S; Wang X; Marshall NB; Rohlman D; Funatake C; Punj S; O'Donnell E; Yu Z; Kolluri SK; Kerkvliet NI
    Eur J Immunol; 2017 Nov; 47(11):1989-2001. PubMed ID: 28833046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.
    Mezrich JD; Fechner JH; Zhang X; Johnson BP; Burlingham WJ; Bradfield CA
    J Immunol; 2010 Sep; 185(6):3190-8. PubMed ID: 20720200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol Attenuates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Induction of Myeloid-Derived Suppressor Cells (MDSC) and Their Functions.
    Neamah WH; Rutkovsky A; Abdullah O; Wilson K; Bloomquist R; Nagarkatti P; Nagarkatti M
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosstalk between PPARγ Ligands and Inflammatory-Related Pathways in Natural T-Regulatory Cells from Type 1 Diabetes Mouse Model.
    Nor Effa SZ; Yaacob NS; Mohd Nor N
    Biomolecules; 2018 Nov; 8(4):. PubMed ID: 30400642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of FluoAHRL: A Novel Synthetic Fluorescent Compound That Activates AHR and Potentiates Anti-Inflammatory T Regulatory Cells.
    Jonić N; Koprivica I; Chatzigiannis CM; Tsiailanis AD; Kyrkou SG; Tzakos EP; Pavić A; Dimitrijević M; Jovanović A; Jovanović MB; Marinho S; Castro-Almeida I; Otašević V; Moura-Alves P; Tzakos AG; Stojanović I
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation.
    Mezrich JD; Nguyen LP; Kennedy G; Nukaya M; Fechner JH; Zhang X; Xing Y; Bradfield CA
    PLoS One; 2012; 7(9):e44547. PubMed ID: 22970246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential for TCDD to induce regulatory functions in B cells as part of the mechanism for T cell suppression in EAE.
    McDonald A; Nicaise A; Sears ER; Bell A; Kummari E; Kaplan BLF
    Toxicol Appl Pharmacol; 2022 Nov; 454():116259. PubMed ID: 36179859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of the IgM Response by Aryl Hydrocarbon Receptor Activation in Human Primary B Cells Involves Impairment of Immunoglobulin Secretory Processes.
    Zhou J; Henriquez J; Crawford R; Kaminski N
    Toxicol Sci; 2018 May; 163(1):319-329. PubMed ID: 29462421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.
    Apetoh L; Quintana FJ; Pot C; Joller N; Xiao S; Kumar D; Burns EJ; Sherr DH; Weiner HL; Kuchroo VK
    Nat Immunol; 2010 Sep; 11(9):854-61. PubMed ID: 20676095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the Aryl Hydrocarbon Receptor Ameliorates Acute Rejection of Rat Liver Transplantation by Regulating Treg Proliferation and PD-1 Expression.
    Cao W; Lu J; Li L; Qiu C; Qin X; Wang T; Li S; Zhang J; Xu J
    Transplantation; 2022 Nov; 106(11):2172-2181. PubMed ID: 35706097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ahr-Foxp3-RORγt axis controls gut homing of CD4
    Xiong L; Dean JW; Fu Z; Oliff KN; Bostick JW; Ye J; Chen ZE; Mühlbauer M; Zhou L
    Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32532834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune diabetes.
    Wang X; Hao J; Metzger DL; Mui A; Ao Z; Akhoundsadegh N; Langermann S; Liu L; Chen L; Ou D; Verchere CB; Warnock GL
    Diabetes; 2011 Dec; 60(12):3246-55. PubMed ID: 21984581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.
    Feuerer M; Jiang W; Holler PD; Satpathy A; Campbell C; Bogue M; Mathis D; Benoist C
    Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18181-6. PubMed ID: 17991775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice.
    Goettel JA; Gandhi R; Kenison JE; Yeste A; Murugaiyan G; Sambanthamoorthy S; Griffith AE; Patel B; Shouval DS; Weiner HL; Snapper SB; Quintana FJ
    Cell Rep; 2016 Oct; 17(5):1318-1329. PubMed ID: 27783946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of CD226 Co-Stimulation Suppresses Diabetes Development in the NOD Mouse by Augmenting Tregs and Diminishing Effector T Cell Function.
    Brown ME; Thirawatananond P; Peters LD; Kern EJ; Vijay S; Sachs LK; Posgai AL; Brusko MA; Shapiro MR; Mathews CE; Bacher R; Brusko TM
    bioRxiv; 2024 Jul; ():. PubMed ID: 39071293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2 responding CD4
    Sandoval S; Malany K; Thongphanh K; Martinez CA; Goodson ML; Souza FDC; Lin LW; Pennington J; Lein PJ; Kerkvliet NI; Ehrlich AK
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The amphiregulin/EGFR axis has limited contribution in controlling autoimmune diabetes.
    Raugh A; Jing Y; Bettini ML; Bettini M
    Sci Rep; 2023 Oct; 13(1):18653. PubMed ID: 37903947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The type 1 diabetes susceptibility locus
    Santamaria JC; Vuillier S; Galindo-Albarrán AO; Castan S; Detraves C; Joffre OP; Romagnoli P; van Meerwijk JPM
    Front Immunol; 2024; 15():1358459. PubMed ID: 38404576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.